Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Surgery Improves Quality of Life in Hyperhidrosis Sufferers

By HospiMedica staff writers
Posted on 27 Aug 2007
A new study has found suction-curettage is an effective, minimally invasive surgery option capable of significantly improving quality of life in patients suffering from focal axillary hyperhidrosis.

Researchers at Ruhr-University Bochum (Germany) assessed quality of life before and up to nine months after suction-curettage in 51 patients with excessive axillary sweating. More...
Before treatment, the median score was 12, with a range of nine to 18 on the Dermatology Life Quality Index (DLQI). Nine months following suction-curettage, a significant decrease of the DLQI score was observed, with a median score of 4 and a range of 2-8. This represents a relative reduction and improvement of the DLQI score of 63.4%. Thirty-five patients (68.6%) reported a sweat reduction of 75% or more and 13 reported a 50% to 75% sweat reduction. The study was published in the August 2007 issue of the Journal of the American Academy of Dermatology.

"Patient satisfaction with the surgical procedure was high, with 78.4% of the patients being very or completely satisfied with suction-curettage,” said lead author Dr. Falk G. Bechara, from the department of dermatology and allergology. "Suction-curettage is a good therapeutic option that may improve quality of life for these patients.”

Focal axillary hyperhidrosis is a medical condition characterized by abnormally increased perspiration in the axillas (armpits). Sufferers feel at a loss of control because perspiration takes place independent of temperature and emotional state.


Related Links:
Ruhr-University Bochum

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.